scholarly journals A Cost-Utility Analysis Comparing Two Sequences of Treatment for First-Line Chemotherapy in Metastatic Prostate Cancer (MCRPC): Cabazitaxel Followed by Docetaxel Versus Docetaxel Followed by Cabazitaxel

2017 ◽  
Vol 20 (9) ◽  
pp. A444 ◽  
Author(s):  
M Schwager ◽  
K Fizazi ◽  
N Zaghdoud ◽  
R Delva ◽  
G Gravis Mescam ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Metastatic Prostate Cancer ◽  
Cost Utility ◽  
Cost Utility Analysis ◽  
Utility Analysis ◽  
First Line ◽  
Line Chemotherapy

scholarly journals CN2 COST-UTILITY ANALYSIS OF LHRH AGONISTS IN THE TREATMENT OF METASTATIC PROSTATE CANCER

2002 ◽  
Vol 5 (3) ◽  
pp. 129-130 ◽  
Author(s):  
M Hemels ◽  
M Iskedjian ◽  
N Iscoe ◽  
N Fleshner ◽  
T Einarson
Keyword(s):  
Prostate Cancer ◽  
Metastatic Prostate Cancer ◽  
Cost Utility ◽  
Cost Utility Analysis ◽  
Utility Analysis ◽  
Lhrh Agonists

scholarly journals COST-UTILITY ANALYSIS OF ANDROGEN ABLATION THERAPY IN METASTATIC PROSTATE CANCER

2003 ◽  
Vol 94 (4) ◽  
pp. 503-512
Author(s):  
Keita Fujikawa ◽  
Yasuo Awakura ◽  
Tatsushiro Okabe ◽  
Rei Watanabe ◽  
Shuzo Nishimura
Keyword(s):  
Prostate Cancer ◽  
Metastatic Prostate Cancer ◽  
Cost Utility ◽  
Cost Utility Analysis ◽  
Utility Analysis ◽  
Ablation Therapy ◽  
Androgen Ablation ◽  
Androgen Ablation Therapy
Sign in / Sign up

Export Citation Format

Share Document